Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Relapse Rate Reduced by Home Monitoring of IBD Patients Tightly or on Demand by FC and Disease Activity?

NCT02492555 is registered in ClinicalTrials.gov with Nordsjaellands Hospital as lead sponsor.

NCT NCT02492555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02492555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Relapse Rate Reduced by Home Monitoring of IBD Patients Tightly or on Demand by FC and Disease Activity?
Lead sponsor
Nordsjaellands Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2015
Completion date
November 30, 2017
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease